New diabetes pill study shows real-world results for blood sugar and weight
NCT ID NCT05443334
First seen Sep 30, 2025 · Last updated Jun 16, 2026 · Updated 30 times
Summary
This study looked at how well the once-daily pill Rybelsus® (oral semaglutide) works for adults with type 2 diabetes in Spain. Researchers tracked changes in blood sugar levels, body weight, and how satisfied patients were with their treatment over 8-10 months. The goal was to see how the medicine performs in real-world settings, outside of a controlled clinical trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Master Centre for Spain
Barcelona, 08025, Spain
-
Master Centre for Spain
Madrid, 28033, Spain
Conditions
Explore the condition pages connected to this study.